GEHC · GE Healthcare Technologies Inc
Price
Snapshot
50 fields · last close| Market Cap | $31.49B |
| P/E | 16.79 |
| Float | 450.0M |
| Beta | 0.82 |
| Volatility | 20.5% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 71 |
| Price | 68.79 |
| Change | −1.33% |
| Prev Close | 69.72 |
| Open | 71.02 |
| Day Low | 68.50 |
| Day High | 71.36 |
| Avg Vol | 2 |
| Avg $ Vol | $170.8M |
| 52W High | 89.77 |
| 52W Low | 58.75 |
| 52W Pos | 32.4% |
| From High | −23.37% |
| From Low | +17.09% |
| Max DD 1Y | −32.53% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −5.33% |
| SMA 50 | +0.84% |
| SMA 200 | −5.44% |
| RSI (14) | 44.8 |
| Vol 30D | 42.6% |
| Vol 90D | 42.8% |
| 1Y Range | 59–90 |
| Daily bars | 506 |
| Perf Week | −3.81% |
| Perf Month | −0.74% |
| Perf Quarter | +9.26% |
| Perf Half Y | −9.58% |
| Perf Year | −3.68% |
| Perf YTD | −16.94% |
| Prev Day | −1.33% |
| Clavix | B- |
| Debt / Eq | 0.97 |
| Curr Ratio | 1.37 |
| Int Cover | 7.9× |
| FCF Margin | 7.2% |
| Rev Growth | +5.8% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 33 / 47 |
What GEHC does
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women’s health products.
The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products.
The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products.
The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries.
The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.
The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022.
The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Clavix risk grade
regraded every trading dayGEHC grades B-, 71 of 100. Steadiest on News Sentiment (67), most exposed on Price Stability (54, mixed). 0 of the 4 weighted dimensions sit above the Health Care median. Ranks 33 of 47 in Health Care by Clavix score.
How rough the ride is
| GEHC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.82 | 0.81 |
| Volatilityannualized | 20.5% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −32.5% | — |
| Typical daily movemedian absolute daily change | 1.14% | — |
| Days beyond ±3%of the last 252 sessions | 3213% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| GEHC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.82 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| GEHC | |
|---|---|
| 1 week | −3.8% |
| 1 month | −0.7% |
| Year to date | −16.9% |
| 1 year | −3.7% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| GEHC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 23 Jul |
| Average score0 most bearish, 100 most bullish | 69 |
| Bullish · bearisharticles above 60 · below 40 | 23 · 0 |
| Directionarticles whose tone is improving vs worsening | 23 ↑ 0 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| GEHC | |
|---|---|
| Revenue growthyear over year | +5.8% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | GEHC | Sector spread | Median |
|---|---|---|---|
| Beta | 0.82 | 0.81 | |
| Volatility | 20.5% | 20.4% | |
| P/E | 16.79 | 26.14 | |
| Debt / equity | 0.97 | 0.71 | |
| Current ratio | 1.37 | 1.58 | |
| FCF margin | 7.2% | 8.6% | |
| Interest coverage | 7.9× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openGE HealthCare received CE Mark approval for its Photonova Spectra scanner, a photon-counting CT (computed tomography/X-ray) imaging system using Deep Silicon detector technology, allowing it to be sold in Europe and other CE-mark markets.
GE HealthCare Technologies said William K. Grogan, who previously held finance leadership roles at Xylem and IDEX, will become its new Chief Financial Officer on September 14, 2026. The article also notes the stock is up 22% over the past 30 days and 15.7% over the past 90 days, but down 10.76% year to date.
GE HealthCare has a record backlog and strong growth in Pharmaceutical Diagnostics, while its AI-related innovation supports the company's growth outlook. The article also notes pressure on profit margins.
An article recommends adding GE HealthCare stock to a portfolio, citing a record backlog, strong growth in its Pharmaceutical Diagnostics segment, and AI innovation as positives, while noting margin pressures remain a concern.
BTIG Research reaffirmed its 'Buy' rating on GE HealthCare Technologies with a $79.00 price target. The article provides no new information about the company's business.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| RMD | Resmed Inc | B+ | $33.06B | 21.74 | 0.77 | Compare |
| ALC | Alcon AG | B+ | $29.66B | 44.75 | 1.12 | Compare |
| CNC | Centene Corp | B | $33.60B | — | 1.08 | Compare |
| DXCM | Dexcom Inc | B | $33.85B | 33.86 | 1.45 | Compare |
| VEEV | Veeva Systems Inc | B- | $34.18B | 45.52 | 0.91 | Compare |
| LH | Labcorp Holdings Inc | A- | $26.88B | 26.91 | 0.88 | Compare |
| DGX | Quest Diagnostics Inc | A- | $26.42B | 24.97 | 0.56 | Compare |
| IDXX | IDEXX Laboratories Inc | B+ | $41.70B | 36.69 | 1.57 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.